Boehringer signs AI drug discovery deal with Owkin
Boehringer Ingelheim has joined Sanofi and AstraZeneca in signing up to deploy Owkin's AI platform K Pro in its drug discovery operations.
Newsletters and Deep Dive digital magazine
Boehringer Ingelheim has joined Sanofi and AstraZeneca in signing up to deploy Owkin's AI platform K Pro in its drug discovery operations.
The MHRA has teamed up with a Manchester NHS trust to set up a regional innovation 'sandbox' to test new technologies like AI in clinical settings.
Federal funding from ARPA-H of $125m, awarded to five groups, is part of a drive to accelerate patient access to personalised genetic medicines.
Anthropic has opened a research preview of its Model Hardware Standard (MHS), the company's first tool designed to operate in the physical world.
Digital mental health company Headspace will be acquired by Sword Health next month, according to regulatory filings.
Editor's Picks
Newsletters and Deep Dive
digital magazine